FindTrial
Sign In

Double-Blind Study of Miglitol in Japanese With type2 Diabetes

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00380822
Enrollment
Unknown
Registered
2006-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2006-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Keywords

alpa-glucosidase inhibitor

Brief summary

To investigate the efficacy and safety of miglitol in Japanese patients with type 2 diabetes that is insufficiently controlled diet alone.

Interventions

DRUGmiglitol

Sponsors

Sanwa Kagaku Kenkyusho Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
20 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Type2 diabetic patient on Dietary Therapy * Criteria for postprandial plasma glucose and HbA1c are met

Exclusion criteria

* Type1 diabetes * Patients treated with antidiabetic drugs or Insulin

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026